On October 29, 2026, Gexin Liu sold 82,800 shares of SKB BIO (06990) on the SEHK open market at an average of HKD 441.9200 per share, involving about HKD 36.59 million; per the supplemental note, the sale was executed via employee shareholding platforms he controls with aggregate sales not exceeding 10% of the day’s trading volume, and it was an on-exchange active trade matched on the SEHK open market, a direct secondary-market dealing.
Prior to the disposal, Gexin Liu’s long position in SKB BIO was 86.17 million shares, representing 48.73%; following the disposal, the holding changed to 86.08 million shares, with the long position ratio falling to 48.68%.
Source: Hong Kong Exchanges and Clearing Limited.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
Comments